(Q40622507)

22 September 2017

1 reference

title

Paclitaxel (Taxol): a novel anticancer chemotherapeutic drug (English)

1 reference

22 September 2017

1 reference

1 reference

H J Long

1

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

69

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

341-345

1 reference

Antineoplastic Agents from Plants

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

7 January 2021

Taxol in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Promotion of microtubule assembly in vitro by taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Taxol stabilizes microtubules in mouse fibroblast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

A phase I trial of taxol given by a 6-hour intravenous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Hypersensitivity reactions from taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Cardiac disturbances during the administration of taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

A phase II trial of taxol in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

A phase II study of taxol in patients with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Phase II Trial of Taxol in Patients with Metastatic Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Taxol administered as a 120 hour infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

Sequences of taxol and cisplatin: a phase I and pharmacologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962219-8

10.1016/S0025-6196(12)62219-8

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference